雌激素与双膦酸盐影响绝经后骨质疏松症作用机制的比较

被引：5

作者：

宫伟雁

王绍海

林守清

机构：

[1] 中国医学科学院北京协和医院西区妇产科

来源：

北京医学 | 2008年 / 06期

关键词：

D O I：

暂无

中图分类号：

R580 [];

学科分类号：

摘要：

<正>绝经后骨质疏松症(postmenopausa losteoporosisPMO)发生的主要机制是雌激素缺乏后骨转换加快,同时骨吸收多于骨形成,导致骨量下降。雌激素(e-strogen,E)和双膦酸盐(bisphosphonates,BPs)以其抗骨吸收作用,成为临床抗骨质疏松症的主要药物。

引用

页码：356 / 359

页数：4

共 8 条

[1]

Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients [J].

Dobnig, H ;

Hofbauer, LC ;

Viereck, V ;

Obermayer-Pietsch, B ;

Fahrleitner-Pammer, A .

OSTEOPOROSIS INTERNATIONAL, 2006, 17 (05) :693-703

[2]

Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy, or combination therapy: A three-year, double-blind, placebo-controlled, randomized clinical trial [J].

Greenspan, SL ;

Resnick, NM ;

Parker, RA .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) :2762-2767

[3]

Clodronate stimulates osteoblast differentiation in ST2 and MC3T3-E1 cells and rat organ cultures [J].

Itoh, F ;

Aoyagi, S ;

Furihata-Komatsu, H ;

Aoki, M ;

Kusama, H ;

Kojima, M ;

Kogo, H .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 477 (01) :9-16

[4]

Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by three-dimensional microcomputed tomography [J].

Dufresne, TE ;

Chmielewski, PA ;

Manhart, MD ;

Johnson, TD ;

Borah, B .

CALCIFIED TISSUE INTERNATIONAL, 2003, 73 (05) :423-432

[5]

Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells:: The role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors [J].

Van Beek, ER ;

Löwik, CWGM ;

Papapoulos, SE .

BONE, 2002, 30 (01) :64-70

[6]

Estrogen regulation of growth and alkaline phosphatase expression by cultured human bone marrow stromal cells [J].

Holzer, G ;

Einhorn, TA ;

Majeska, RJ .

JOURNAL OF ORTHOPAEDIC RESEARCH, 2002, 20 (02) :281-288

[7]

Bone remodeling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy [J].

Vedi, S ;

Purdie, DW ;

Ballard, P ;

Bord, S ;

Cooper, AC ;

Compston, JE .

OSTEOPOROSIS INTERNATIONAL, 1999, 10 (01) :52-58

[8]

Comparison of cytotoxic effects of bisphosphonates in vitro and in vivo [J].

Ito, M ;

Chokki, M ;

Ogino, Y ;

Satomi, Y ;

Azuma, Y ;

Ohta, T ;

Kiyoki, M .

CALCIFIED TISSUE INTERNATIONAL, 1998, 63 (02) :143-147

← 1 →